Skip to content

Omnicell OMCL Free cash flow yield

Free cash flow yield at other companies

Baxter International logo
Baxter InternationalBAX
3.4%-0.5pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
7.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
5%
Cardinal Health logo
Cardinal HealthCAH
8.8%+1.5pp
Cencora logo
CencoraCOR
5.6%+4.7pp
ICU Medical logo
ICU MedicalICUI
2.9%-1.0pp

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Omnicell’s reported figures.

Based on trailing twelve months.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's free cash flow yield?
Omnicell (OMCL) reported free cash flow yield of 7.5% in Q1 2026.
How has Omnicell's free cash flow yield changed year-over-year?
Omnicell's free cash flow yield decreased by 1.5% year-over-year, from 7.6% to 7.5%.
What is the long-term trend for Omnicell's free cash flow yield?
Over 5 years (2020 to 2025), Omnicell's free cash flow yield has grown at a 6.7% compound annual growth rate (CAGR), from 3.1% to 4.3%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.